BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38560009)

  • 1. Enhancing Cisplatin Efficacy with Low Toxicity in Solid Breast Cancer Cells Using pH-Charge-Reversal Sericin-Based Nanocarriers: Development, Characterization, and
    Bahremand K; Aghaz F; Bahrami K
    ACS Omega; 2024 Mar; 9(12):14017-14032. PubMed ID: 38560009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codelivery of resveratrol melatonin utilizing pH responsive sericin based nanocarriers inhibits the proliferation of breast cancer cell line at the different pH.
    Aghaz F; Asadi Z; Sajadimajd S; Kashfi K; Arkan E; Rahimi Z
    Sci Rep; 2023 Jul; 13(1):11090. PubMed ID: 37422485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Interaction of Doxorubicin-Loaded Silk Sericin Nanocarriers with MCF-7 Breast Cancer Cells Leads to DNA Damage.
    Radu IC; Zaharia C; Hudiță A; Tanasă E; Ginghină O; Marin M; Gălățeanu B; Costache M
    Polymers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and biological characterization of sericin-loaded copolymer liposomes stabilized by polyvinyl alcohol.
    Suktham K; Koobkokkruad T; Saesoo S; Saengkrit N; Surassmo S
    Colloids Surf B Biointerfaces; 2016 Dec; 148():487-495. PubMed ID: 27673445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Fabrication of Multifunctional Sericin Nanoparticles for Tumor Targeting and pH-Responsive Subcellular Delivery of Cancer Chemotherapy Drugs.
    Huang L; Tao K; Liu J; Qi C; Xu L; Chang P; Gao J; Shuai X; Wang G; Wang Z; Wang L
    ACS Appl Mater Interfaces; 2016 Mar; 8(10):6577-85. PubMed ID: 26855027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting.
    Jahanshahi M; Kowsari E; Haddadi-Asl V; Khoobi M; Lee JH; Kadumudi FB; Talebian S; Kamaly N; Mehrali M
    Int J Pharm; 2019 Dec; 572():118791. PubMed ID: 31678390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
    Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M
    Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the release process and modelling of in vitro release data of cis-dichlorodiamminoplatinum (II) encapsulated into poly(2-hydroxyethyl methacrylate) nanocarriers.
    Gupta MK; Bajpai J; Bajpai AK
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():852-62. PubMed ID: 26478380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of pH-sensitive chitosan/starch/MoS
    Omrani Z; Pourmadadi M; Yazdian F; Rashedi H
    Int J Biol Macromol; 2023 Oct; 250():125897. PubMed ID: 37481179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of a novel, pH-responsive sustained release nanocarrier using polyethylene glycol, graphene oxide, and natural silk fibroin protein by a green nano emulsification method to enhance cancer treatment.
    Jeshvaghani PA; Pourmadadi M; Yazdian F; Rashedi H; Khoshmaram K; Nigjeh MN
    Int J Biol Macromol; 2023 Jan; 226():1100-1115. PubMed ID: 36435465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
    Ghaferi M; Asadollahzadeh MJ; Akbarzadeh A; Ebrahimi Shahmabadi H; Alavi SE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells.
    Haque ST; Karim ME; Abidin SAZ; Othman I; Holl MMB; Chowdhury EH
    Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32349272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
    Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
    Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A green approach for preparation of polyacrylic acid/starch incorporated with titanium dioxide nanocomposite as a biocompatible platform for curcumin delivery to breast cancer cells.
    Pourmadadi M; Tajiki A; Abdouss M
    Int J Biol Macromol; 2023 Jul; 242(Pt 1):124785. PubMed ID: 37169052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiffness-tuneable nanocarriers for controlled delivery of ASC-J9 into colorectal cancer cells.
    Tomeh MA; Hadianamrei R; Sun W; Xu D; Brown S; Zhao X
    J Colloid Interface Sci; 2021 Jul; 594():513-521. PubMed ID: 33774407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug Delivery.
    Parveen F; Madni A; Torchilin VP; Rehman M; Jamshaid T; Filipczak N; Rai N; Khan MM; Khan MI
    Int J Nanomedicine; 2022; 17():2413-2434. PubMed ID: 35656165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of resveratrol-loaded sericin nanoparticles: Promising bionanocarriers for drug delivery.
    Suktham K; Koobkokkruad T; Wutikhun T; Surassmo S
    Int J Pharm; 2018 Feb; 537(1-2):48-56. PubMed ID: 29229512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-Responsive, Plasmonic Nanogel for Dual Delivery of Curcumin and Photothermal Therapy for Cancer Treatment.
    Howaili F; Özliseli E; Küçüktürkmen B; Razavi SM; Sadeghizadeh M; Rosenholm JM
    Front Chem; 2020; 8():602941. PubMed ID: 33585400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco Mosaic Virus-Delivered Cisplatin Restores Efficacy in Platinum-Resistant Ovarian Cancer Cells.
    Franke CE; Czapar AE; Patel RB; Steinmetz NF
    Mol Pharm; 2018 Aug; 15(8):2922-2931. PubMed ID: 28926265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.